TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
-3.2%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$3.36B
AUM Growth
-$1.68B
(-33%)
Cap. Flow
-$1.35B
Cap. Flow
% of AUM
-40.17%
Top 10 Holdings %
Top 10 Hldgs %
28.65%
Holding
6,080
New
403
Increased
1,949
Reduced
2,725
Closed
953
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$249M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$21M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$18.3M |
| 4 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$15.6M |
| 5 |
Exxon Mobil
XOM
|
+$14.9M |
Top Sells
| 1 |
Apple
AAPL
|
+$120M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$94.5M |
| 3 |
Microsoft
MSFT
|
+$85.3M |
| 4 |
NVIDIA
NVDA
|
+$83M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$38.8M |
Sector Composition
| 1 | Technology | 19.99% |
| 2 | Financials | 9.87% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Healthcare | 7.96% |
| 5 | Communication Services | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3926
GEN Restaurant Group
GENK
$16.1M
| $7.87K | ﹤0.01% |
1,426
+1,229
| +624% | +$6.78K |
|
3927
Reviva Pharmaceuticals
RVPH
$29.4M
| $7.87K | ﹤0.01% |
8,247
-18,528
| -69% | -$17.7K |
|
3928
Skye Bioscience
SKYE
$126M
| $7.85K | ﹤0.01% |
4,938
+1,707
| +53% | +$2.71K |
|
3929
Neurogene
NGNE
$249M
| $7.85K | ﹤0.01% |
670
+41
| +7% | +$480 |
|
|
ARTV
3930
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$57.4M
| $7.84K | ﹤0.01% |
2,614
+1,402
| +116% | +$4.21K |
|
|
GRCE
3931
Grace Therapeutics, Inc. Common Stock
GRCE
$42.5M
| $7.82K | ﹤0.01% |
3,429
+1,932
| +129% | +$4.41K |
|
3932
Banzai International
BNZI
$8.35M
| $7.8K | ﹤0.01% |
697
+605
| +658% | +$6.77K |
|
3933
BGSF Inc
BGSF
$87.9M
| $7.8K | ﹤0.01% |
2,120
-3,367
| -61% | -$12.4K |
|
3934
ZimVie
ZIMV
$533M
| $7.79K | ﹤0.01% |
721
-411
| -36% | -$4.44K |
|
3935
Lucid Diagnostics
LUCD
$108M
| $7.74K | ﹤0.01% |
5,193
-1,976
| -28% | -$2.94K |
|
|
ORKA
3936
Oruka Therapeutics, Inc. Common Stock
ORKA
$571M
| $7.74K | ﹤0.01% |
754
+170
| +29% | +$1.74K |
|
|
RIME
3937
Algorhythm Holdings, Inc. Common Stock
RIME
$5.33M
| $7.72K | ﹤0.01% |
3,592
+3,372
| +1,533% | +$7.25K |
|
3938
Lincoln Educational Services
LINC
$654M
| $7.63K | ﹤0.01% |
481
-712
| -60% | -$11.3K |
|
|
CJMB
3939
Callan JMB Inc. Common Stock
CJMB
$21.6M
| $7.63K | ﹤0.01% |
+1,700
| New | +$7.63K |
|
3940
iShares MSCI Singapore ETF
EWS
$818M
| $7.63K | ﹤0.01% |
321
+108
| +51% | +$2.57K |
|
|
BLNE
3941
Beeline Holdings, Inc. Common Stock
BLNE
$66.9M
| $7.62K | ﹤0.01% |
4,143
+3,685
| +805% | +$6.78K |
|
3942
iShares MSCI South Africa ETF
EZA
$445M
| $7.58K | ﹤0.01% |
158
-550
| -78% | -$26.4K |
|
3943
BankFinancial
BFIN
$151M
| $7.57K | ﹤0.01% |
+599
| New | +$7.57K |
|
3944
Immersion
IMMR
$229M
| $7.54K | ﹤0.01% |
995
-632
| -39% | -$4.79K |
|
3945
A-Mark Precious Metals
AMRK
$667M
| $7.51K | ﹤0.01% |
296
-3,139
| -91% | -$79.6K |
|
3946
VirTra
VTSI
$64.6M
| $7.51K | ﹤0.01% |
1,844
-180
| -9% | -$733 |
|
3947
Traws Pharma
TRAW
$14.6M
| $7.5K | ﹤0.01% |
+3,261
| New | +$7.5K |
|
3948
Liberty Broadband Class C
LBRDK
$8.6B
| $7.48K | ﹤0.01% |
88
-2,240
| -96% | -$191K |
|
3949
Gogoro
GGR
$95.6M
| $7.45K | ﹤0.01% |
+27,577
| New | +$7.45K |
|
3950
iShares US Financial Services ETF
IYG
$1.93B
| $7.45K | ﹤0.01% |
+100
| New | +$7.45K |
|